Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CONGRESSIONAL FDA OVERSIGHT EXPERIENCE TO DWINDLE IN LIGHT OF STAFF CUTS

This article was originally published in The Tan Sheet

Executive Summary

CONGRESSIONAL FDA OVERSIGHT EXPERIENCE TO DWINDLE IN LIGHT OF STAFF CUTS anticipated in key committees and subcommittees that oversee the agency. The new Republican House leadership said it intends to "review every aspect of the current organizational structure of the House," and may consider trimming the large number of committees and their staffs. The change of control in the House will lead to the dismantling of the large, well- established committee staffs as well as the replacement of the Democratic committee chairs. At Energy & Commerce, Rep. John Dingell's (D-Mich.) aggressive investigative staff will be subject to large cuts.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083421

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel